Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patients.
Future Sci OA
; 7(4): FSO689, 2021 Feb 15.
Article
in En
| MEDLINE
| ID: mdl-33815827
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Future Sci OA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: